GMED vs PROF
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 03, 2026
GMED
53.9
AI Score
VS
PROF Wins
PROF
67.6
AI Score
Investment Advisor Scores
PROF
68score
Recommendation
BUY
AI Analyst Insights
AI insights temporarily unavailable
Detailed Metrics Comparison
| Metric | GMED | PROF | Winner |
|---|---|---|---|
| Revenue | 1.55B | 10.12M | GMED |
| Net Income | 275.87M | -34.40M | GMED |
| Net Margin | 17.8% | -339.8% | GMED |
| Operating Income | 332.82M | -33.88M | GMED |
| ROE | 5.8% | -107.0% | GMED |
| ROA | 5.0% | -81.3% | GMED |
| Total Assets | 5.49B | 42.30M | GMED |
| Cash | 507.75M | 24.83M | GMED |
| Current Ratio | 4.62 | 4.18 | GMED |
Relative Price Performance (Last 90 Days)
GMED 1M: -6.3%
· 3M: -6.1%
PROF 1M: -14.4%
· 3M: -20.8%
Current Technical Phase
GMED
NeutralHold
Mixed signals - no dominant trend phase, RSI 46
PROF
MarkdownSell / avoid
Price below a falling SMA50 (slope -5.4%), weak momentum, RSI 42
Fundamentals Snapshot
| Metric | GMED | PROF |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 14.0 | -9.9 |
| Trailing P/E | 19.2 | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.1% | 0.1% |
| Gross Margin | 0.7% | 0.7% |
| Operating Margin | 0.2% | -4.5% |
| EPS | 3.88 | -1.00 |
| Dividend Yield | — | — |
Frequently Asked Questions
Based on our detailed analysis, PROF is currently the stronger investment candidate based on our comprehensive scoring model.
We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.
Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.